Fairjourney biologics acquires charles river laboratories south san francisco facility

Porto, portugal & san francisco--(business wire)--fairjourney biologics s.a., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the south san francisco site from charles river laboratories international, inc. the acquisition aligns with fairjourney's ongoing strategic growth plan, and will significantly bolster the company's antibody discovery and engineering capabilities, strengthening its technology portfolio and expanding its gl.
CRL Ratings Summary
CRL Quant Ranking